Table 2. Univariate and multivariate analyses of E-cadherin expression in disease-free survival and overall survival.
Variable analysis | Disease-Free Survival | Overall Survival | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p | HR | 95% CI | p | |
Univariate | N = 125 | N = 125 | ||||
E-cadherin | 0.229 | 0.053–0.991 | 0.049 | 0.028 | 0.001–15.090 | 0.266 |
Multivariate | N = 125 | N = 125 | ||||
Gender | 0.749 | 0.279–2.008 | 0.565 | 0.541 | 0.111–2.637 | 0.447 |
Age | 0.281 | 0.101–0.786 | 0.016 | 0.149 | 0.028–0.786 | 0.025 |
Size | 0.708 | 0.209–2.400 | 0.579 | 0.505 | 0.061–4.207 | 0.528 |
Stage | 1.779 | 1.007–3.142 | 0.047 | 2.165 | 0.951–4.930 | 0.066 |
Necrosis | 2.346 | 0.734–7.500 | 0.150 | 1.298 | 0.250–6.750 | 0.756 |
Fuhrman | 1.249 | 0.736–2.118 | 0.409 | 1.868 | 0.841–4.150 | 0.125 |
E-cadherin | 0.206 | 0.046–0.928 | 0.040 | 0.000 | 0.000–4.007E205 | 0.960 |
The variables were compared in the following ways: Age, ≥ 57 years vs. < 57 years; Gender, male vs. female; E-cadherin expression, positive vs. negative; size, > 5.25 vs. < 5.25; Stage, III–IV vs. I–II; Necrosis, yes vs. no; Fuhrman grade, G3-4 vs. G1-2.